SUPRIYA Q3 FY26 Earnings Call Transcript & Analysis
Revenue (Q3 FY26) ₹206 cr (+11% YoY); EBITDA (Q3 FY26) ₹72 cr (+9% YoY); EBITDA Margin (Q3 FY26) 35%. Revenue from operations grew 11% YoY to ₹206 crores in Q3 FY26.
Read full transcript & analysis
Every earnings call for SUPRIYA — management tone, guidance, KPIs and promise tracking, quarter by quarter.
SUPRIYA · 6 transcripts · Healthcare · latest Q3 FY26Revenue (Q3 FY26) ₹206 cr (+11% YoY); EBITDA (Q3 FY26) ₹72 cr (+9% YoY); EBITDA Margin (Q3 FY26) 35%. Revenue from operations grew 11% YoY to ₹206 crores in Q3 FY26.
Read full transcript & analysisRevenue ₹200 cr (+20% YoY); EBITDA ₹73 cr (+12% YoY); EBITDA Margin 36%. Revenue for Q2 FY26 stood at INR 200 crores, reflecting a 20% YoY growth and 38% sequential growth.
Read full transcript & analysisRevenue ₹145 cr (−10% YoY); EBITDA ₹52 cr (−17% YoY); EBITDA Margin 36%. Revenue for Q1 FY26 stood at ₹145 crores, reflecting a 10% year-on-year decline from ₹161 crores in Q1 FY25.
Read full transcript & analysisRevenue ₹184 cr (+16% YoY); EBITDA ₹68 cr (+22% YoY); EBITDA Margin 37.0%. FY25 Revenue: Rs. 696 crores, up 22% YoY.
Read full transcript & analysisRevenue (Q3 FY25) ₹186 cr (+33% YoY); EBITDA (Q3 FY25) ₹66 cr (+59% YoY); EBITDA Margin (Q3 FY25) 35.5%. Revenue from operations grew by 33% YoY to approximately INR 186 crores in Q3 FY25.
Read full transcript & analysisRevenue ₹161 cr (+22% YoY); EBITDA ₹62 cr (+40% YoY); EBITDA Margin 39.0%. Revenue from operations grew 22% YoY to ₹161 crores in Q1 FY25.
Read full transcript & analysis